Adjunctive Brivaracetam in Focal Epilepsy: Real-World Evidence from the BRIVAracetam add-on First Italian netwoRk STudy (BRIVAFIRST)Simona Lattanzi, Domenico Ciampanelli, Sara Casciato et al.|CNS Drugs|2021Cited by 56
Perampanel as precision therapy in rare genetic epilepsiesAndreea Nissenkorn, Angelo Russo, Gerhard Kluger et al.|Epilepsia|2023Cited by 43
Adjunctive Brivaracetam in Older Patients with Focal Seizures: Evidence from the BRIVAracetam add‑on First Italian netwoRk Study (BRIVAFIRST)Simona Lattanzi, Roberta Ciuffini, Laura Canafoglia et al.|Drugs & Aging|2022Cited by 21
Brivaracetam as Early Add-On Treatment in Patients with Focal Seizures: A Retrospective, Multicenter, Real-World StudySimona Lattanzi, Roberta Ciuffini, Laura Canafoglia et al.|Neurology and Therapy|2022Cited by 16
Brivaracetam as add-on treatment in patients with post-stroke epilepsy: real-world data from the BRIVAracetam add-on First Italian netwoRk Study (BRIVAFIRST)Simona Lattanzi, Dario Cocito, Laura Canafoglia et al.|Seizure|2022Cited by 15